A MULTICENTER, OPEN-LABEL TRIAL TO ASSESS THE SAFETY AND TOLERABILITY OF A SINGLE INTRAVENOUS LOADING DOSE OF LACOSAMIDE FOLLOWED BY ORAL MAINTENANCE AS ADJUNCTIVE THERAPY IN SUBJECTS WITH PARTIAL-ONSET SEIZURES: AN INTERIM REPORT

被引：0
|
作者：
Fountain, N. B. [1 ]
Krauss, G. [1 ]
Isojarvi, J. [1 ]
Dilley, D. [1 ]
Doty, P. [1 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
来源：
EPILEPSIA | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [21] Long-Term Safety and Tolerability of Lacosamide for Partial-Onset Seizures: An Interim Evaluation of Patients Exposed to Lacosamide in Double-Blind and Open-Label Trials
    Rosenfeld, William
    Rosenow, Felix
    Isojarvi, Jouko
    Hebert, David
    Doty, Pamela
    NEUROLOGY, 2010, 74 (09) : A452 - A453
  • [22] Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial
    Zadeh, Wendy Waldman
    Escartin, Antonio
    Byrnes, William
    Tennigkeit, Frank
    Borghs, Simon
    Li, Ting
    Dedeken, Peter
    De Backer, Marc
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2015, 31 : 72 - 79
  • [23] Multicenter open-label trial investigating safety and tolerability of intravenous SPM 927 as replacement for oral SPM 927 in subjects with partial seizures
    Vaiciene, N.
    Mameniskiene, R.
    Biton, V.
    Brock, M.
    Sommerville, K.
    EPILEPSIA, 2006, 47 : 146 - 146
  • [24] Long-Term Safety of Lacosamide as Adjunctive Therapy in Patients with Uncontrolled Partial-Onset Seizures: Results from a Phase III Open-Label Extension Trial
    Husain, Aatif
    Faught, Raymond Edward
    Chung, Steve
    Isojarvi, Jouko
    McShea, Cindy
    Doty, Pamela
    NEUROLOGY, 2011, 76 (09) : A291 - A291
  • [25] Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trial
    Mario López-Gómez
    Teresa Corona
    Araceli Diaz-Ruiz
    Camilo Ríos
    Neurological Sciences, 2011, 32 : 1063 - 1067
  • [26] Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial
    Vossler, David G.
    Wechsler, Robert T.
    Williams, Paulette
    Byrnes, William
    Therriault, Sheila
    EPILEPSIA, 2016, 57 (10) : 1625 - 1633
  • [27] Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years
    Rosenfeld, William
    Fountain, Nathan B.
    Kaubrys, Gintaras
    Ben-Menachemd, Elinor
    McShea, Cindy
    Isojarvi, Jouko
    Doty, Pamela
    EPILEPSY & BEHAVIOR, 2014, 41 : 164 - 170
  • [28] Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trial
    Lopez-Gomez, Mario
    Corona, Teresa
    Diaz-Ruiz, Araceli
    Rios, Camilo
    NEUROLOGICAL SCIENCES, 2011, 32 (06) : 1063 - 1067
  • [29] Lacosamide: Safety and tolerability of adjunctive intravenous lacosamide as short-term replacement for oral lacosamide in subjects with partial-onset seizures during 30-, 15-, and 10-minute infusions
    Krauss, G.
    Ben-Menachem, E.
    Mameniskiene, R.
    Vaiciene, N.
    Rudd, D.
    Brock, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 319 - 320
  • [30] Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures
    Lerche, Holger
    Daniluk, Jerzy
    Lotay, Narinder
    DeRossett, Sarah
    Edwards, Suzanne
    Brandt, Christian
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2015, 30 : 93 - 100
12345